NTNX Form 144 Filed for 10,241 Shares from Restricted and Performance Awards
Rhea-AI Filing Summary
Form 144 filed for Nutanix, Inc. (NTNX) reporting a proposed sale of 10,241 common shares through Morgan Stanley Smith Barney LLC on 09/30/2025 on NASDAQ, with an aggregate market value of $783,731.44. The filing shows the shares were acquired on 09/15/2025 from the issuer as restricted stock (5,561 shares) and performance shares (4,680 shares). No securities were reported sold in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.
Positive
- Clear disclosure of the number of shares to be sold (10,241) and their classification as restricted stock and performance shares
- Filer attestation to not possessing undisclosed material adverse information
Negative
- Key details missing: the beneficial owner identity and intended sale price are not provided in the filing
- No indication whether the sale is covered by a pre-established Rule 10b5-1 trading plan
Insights
TL;DR Insider plans to sell 10,241 NTNX shares acquired as restricted and performance awards at end of September 2025.
The Form 144 indicates a proposed transaction by a person associated with Nutanix to sell 10,241 common shares via Morgan Stanley Smith Barney LLC on NASDAQ with an asserted market value of $783,731.44. The underlying shares were reported as granted by the issuer on 09/15/2025 and consist of restricted stock and performance shares. There are no reported sales by the same person in the prior three months, suggesting this is a first disposition of these awards. The filer makes the standard Rule 144 attestation regarding material nonpublic information. Documentation is procedural and does not disclose selling price, beneficial owner identity, or any trading plan date.
TL;DR Routine insider reporting of equity award disposition; disclosure is procedural under Rule 144.
The notice documents an intended sale of issuer-granted equity awards and includes the acquisition dates and share counts for restricted and performance shares. As filed, it fulfills the regulatory requirement to notify the market of a proposed sale but does not provide details on holder identity, motivation, or execution timing beyond the approximate sale date. The absence of prior sales in the three-month window is noted; however, the form does not state whether a 10b5-1 plan applies.